{"transactions":[{"id":689522,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":24237,"kind":"person","name":"Riley Jennifer","position":1,"cik":"0002047607","reported_name":"Riley Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-08-12T20:10:17.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":2655,"price":19.5903,"value":52012.2465,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.54 to $19.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":37041,"source":{"system":"sec-edgar","filing":"0002047607-26-000008","document":"form4-08122026_040809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047607/000204760726000008/form4-08122026_040809.xml","form_type":"4"}},{"id":740295,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":24237,"kind":"person","name":"Riley Jennifer","position":1,"cik":"0002047607","reported_name":"Riley Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-06-12T20:43:18.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":588,"price":13.1,"value":7702.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,429 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction."}],"balance_after":39696,"source":{"system":"sec-edgar","filing":"0002047607-26-000006","document":"form4-06122026_080614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047607/000204760726000006/form4-06122026_080614.xml","form_type":"4"}},{"id":764131,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":24237,"kind":"person","name":"Riley Jennifer","position":1,"cik":"0002047607","reported_name":"Riley Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-05-26T20:10:15.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance stock units (\"PSUs\") granted to the Reporting Person on August 19, 2025. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. On May 21, 2026, the Compensation Committee of the Issuer certified achievement of such performance goals. As a result, the shares subject to the PSUs shall fully vest on August 19, 2028, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":36855,"source":{"system":"sec-edgar","filing":"0002047607-26-000004","document":"form4-05262026_040508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047607/000204760726000004/form4-05262026_040508.xml","form_type":"4"}},{"id":874778,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":24237,"kind":"person","name":"Riley Jennifer","position":1,"cik":"0002047607","reported_name":"Riley Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-02T21:23:32.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests twenty-five percent (25%) on February 26, 2027 and the remainder will vest in equal monthly installments over the following three (3) years, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":95000,"derivative":{"exercise_price":17.64,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0002047607-26-000002","document":"form4-03022026_090329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047607/000204760726000002/form4-03022026_090329.xml","form_type":"4"}},{"id":971565,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":24237,"kind":"person","name":"Riley Jennifer","position":1,"cik":"0002047607","reported_name":"Riley Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2025-12-12T21:18:28.000Z","date":"2025-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":637,"price":4.1,"value":2611.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,655 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction."}],"balance_after":2655,"source":{"system":"sec-edgar","filing":"0001470831-25-000411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047607/000147083125000411/form4.xml","form_type":"4"}},{"id":1315693,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":24237,"kind":"person","name":"Riley Jennifer","position":1,"cik":"0002047607","reported_name":"Riley Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T21:06:16.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the Option Shares vest on January 1, 2026 and the remainder of the Option Shares will vest in equal monthly installments over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":7.43,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001578563-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047607/000157856325000002/primary_doc.xml","form_type":"4"}}]}